Announcements Trials
Browse Landscape

Status

Suspended 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 16Neoplasms 12Colorectal Neoplasms 7Prostatic Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Lung Neoplasms 4Polycystic Ovary Syndrome 3Ovarian Neoplasms 3Glioblastoma 3Diabetes Mellitus 3Crohn Disease 3Vulvar Neoplasms 2Uterine Cervical Neoplasms 2Triple Negative Breast Neoplasms 2Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Skin Neoplasms 2Non-alcoholic Fatty Liver Disease 2Multiple Sclerosis 2Irritable Bowel Syndrome 2Glioma 2Endometrial Neoplasms 2Dyslipidemias 2Colonic Neoplasms 2Colitis, Ulcerative 2Celiac Disease 2Carcinoma, Renal Cell 2Arthritis, Rheumatoid 2Vulvar Diseases 1Vitamin D Deficiency 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Observational × Metastatic Castrate Resistant Prostate Cancer × Clear all
NCT03236688 2022-10-06

Detection of ARv7 in the Plasma of Men With Advanced Metastatic Castrate Resistant Prostate Cancer (MCRP)

Exosome Diagnostics, Inc.

Suspended
30 enrolled
Genitourinary

Metastatic Castrate Resistant Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡